Suppr超能文献

普萘洛尔体内治疗后大鼠心脏线粒体能量偶联的改变

Altered energy coupling in rat heart mitochondria following in vivo treatment with propranolol.

作者信息

Katyare S S, Rajan R R

机构信息

Biochemistry Division, Bhabha Atomic Research Centre, Bombay, India.

出版信息

Biochem Pharmacol. 1991 Jul 15;42(3):617-23. doi: 10.1016/0006-2952(91)90325-y.

Abstract

Effects of acute and chronic treatment with propranolol on oxidative phosphorylation in rat heart mitochondria were examined. Acute propranolol treatment resulted in inhibition of coupled respiration with pyruvate + malate and succinate as substrates. Chronic treatment resulted in decreased state 3 respiration rates with all the substrates employed. The net effect of propranolol treatment was decreased ATP-phosphorylation rates suggesting that this was possibly one of the modes of its cardiodepressant activity. Additionally, chronic propranolol treatment brought about a decrease in the content of cytochrome c + c1 in heart mitochondria. Estimation of propranolol concentrations in serum, whole tissue homogenate and heart mitochondria indicated that although the mitochondria accumulated the highest amount of the drug, the intramitochondrial concentration of the drug was one or two orders of magnitude lower than that which is required to bring about inhibition of respiration under in vitro conditions. Besides, the concentrations reached under acute and chronic treatment conditions were almost comparable. The results, therefore, suggest that the action of the drug in vivo may involve more intricate mechanisms than those observed under in vitro conditions.

摘要

研究了普萘洛尔急性和慢性治疗对大鼠心脏线粒体氧化磷酸化的影响。普萘洛尔急性治疗导致以丙酮酸+苹果酸和琥珀酸为底物的偶联呼吸受到抑制。慢性治疗导致使用的所有底物的状态3呼吸速率降低。普萘洛尔治疗的净效应是ATP磷酸化速率降低,表明这可能是其心脏抑制活性的模式之一。此外,普萘洛尔慢性治疗导致心脏线粒体中细胞色素c + c1的含量降低。血清、全组织匀浆和心脏线粒体中普萘洛尔浓度的测定表明,尽管线粒体积累的药物量最高,但线粒体内药物浓度比在体外条件下引起呼吸抑制所需的浓度低一两个数量级。此外,急性和慢性治疗条件下达到的浓度几乎相当。因此,结果表明该药物在体内的作用可能涉及比体外条件下观察到的更复杂的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验